invent
novel
vector
gene
deliveri
host
garner
great
interest
among
scientif
commun
foremost
applic
gene
deliveri
includ
develop
vaccin
therapeut
sever
infecti
genet
diseas
cancer
success
gene
deliveri
platform
two
import
criteria
safeti
effici
tremend
increas
knowledg
molecular
biolog
genom
proteom
immunolog
allow
remark
progress
recombin
dna
technolog
greatli
influenc
develop
novel
vector
system
viral
nonvir
clinic
trial
gene
therapi
vaccin
applic
seen
util
viral
nonvir
vector
signific
major
clinic
trial
reli
viral
vector
primarili
due
follow
reason
viral
vector
natur
well
adapt
infect
host
due
coevolut
virus
host
thu
enabl
effici
deliveri
target
gene
host
cell
express
antigen
host
cell
allow
present
antigen
peptid
mhc
class
result
stimul
cellular
immun
respons
viral
vector
infect
antigenpres
cell
dendrit
cell
macrophag
allow
direct
present
antigen
peptid
mhc
class
mhc
class
ii
viral
protein
act
immun
stimul
provid
strong
adjuv
effect
boost
immun
respons
antigen
commonli
use
viral
vector
clinic
trial
base
adenovirus
adv
retrovirus
poxvirus
herpesvirus
gene
therapi
clinic
trial
adv
vector
current
commonli
use
gene
deliveri
platform
http
wwwabediacomwileyvectorsphp
adv
first
isol
year
ago
human
adenoid
tissu
undergo
spontan
degener
tissu
cultur
although
first
evalu
adv
antitumor
agent
date
back
advent
recombin
dna
technolog
earli
therapeut
potenti
adv
recogn
adv
vector
first
develop
sinc
adv
biolog
studi
thoroughli
adv
vector
greatli
optim
variou
applic
includ
vaccin
vector
gene
therapi
oncolyt
cancer
therapi
cancer
immunotherapi
adenovir
vector
gene
therapi
adv
nonenvelop
virus
icosahedr
capsid
vari
size
nm
dsdna
genom
rang
kb
adv
classifi
famili
adenovirida
divid
five
genera
mastadenoviru
aviadenoviru
atadenoviru
ichtadenoviru
siadenoviru
current
known
serotyp
human
adv
hadv
encompass
speci
g
base
genom
sequenc
adv
capsid
primarili
compos
major
capsid
protein
hexon
fiber
penton
base
determin
tropism
immunogen
viru
rel
less
abund
protein
adv
capsid
call
minor
capsid
protein
includ
core
protein
tp
v
vii
mu
cement
protein
iiia
vi
viii
ix
depend
speci
type
adv
use
varieti
receptor
cell
entri
includ
coxsackievirusadenoviru
receptor
car
heparin
sulfat
proteoglycan
other
advderiv
vector
fulfil
mani
desir
featur
gene
deliveri
platform
although
adv
known
infect
wide
rang
speci
rare
caus
seriou
diseas
immunecompet
host
hadv
associ
selflimit
diseas
human
may
manifest
mild
upper
respiratori
tract
infect
conjunct
gastroenter
ear
infect
depend
hadv
speci
involv
instanc
sever
diseas
function
host
immun
function
rel
innocu
natur
make
adv
particularli
suitabl
develop
safe
vector
system
adv
vector
offer
sever
advantag
includ
abil
infect
wide
rang
divid
nondivid
mammalian
cell
robust
transgen
express
restrict
specif
tissu
employ
tissu
specif
promot
fact
easi
gener
grown
high
titer
inabl
integr
host
genom
minim
risk
insert
mutagenesi
induct
strong
humor
cellular
adapt
immun
respons
transgen
strong
activ
innat
immun
respons
provid
adjuv
effect
potenti
booster
immun
may
desir
vaccin
applic
among
known
hadv
serotyp
biolog
subgroup
c
serotyp
thoroughli
studi
therefor
vector
first
evalu
preclin
studi
vector
show
great
promis
gene
deliveri
due
extrem
strong
transgen
express
highli
optim
system
product
prepar
larg
scale
abil
induc
strong
humor
cellular
immun
respons
nonhuman
primat
well
rodent
result
major
initi
clinic
studi
involv
adv
vector
reli
vector
high
preval
preexist
adv
immun
human
note
major
concern
success
vector
clinic
studi
develop
preexist
adv
immun
mainli
due
exposur
major
human
popul
worldwid
one
hadv
serotyp
natur
infect
result
strong
antihadv
humor
cellular
immun
respons
given
natur
exposur
hadv
highli
variabl
level
preexist
adv
immun
expect
vari
among
individu
human
popul
make
efficaci
hadv
vector
clinic
trial
unpredict
high
immunogen
adv
vector
impli
first
inocul
adv
vector
result
adv
serotypespecif
immun
respons
preclud
subsequ
use
adv
serotyp
thu
high
efficaci
singl
adv
serotyp
expect
even
individu
lack
preexist
adv
immun
humor
immun
respons
hadv
consist
neutral
nonneutr
antibodi
although
antihadvneutr
antibodi
nab
target
three
major
capsid
protein
hexon
penton
fiber
confirm
antihexon
nab
signific
vector
neutral
major
epitop
antihexon
nab
locat
expos
loop
also
known
hypervari
region
locat
surfac
viru
particl
nab
bind
adv
vector
blood
prevent
bind
cell
surfac
subsequ
intern
thu
result
rapid
clearanc
host
end
result
drastic
reduct
transgen
express
induct
transgenespecif
immun
respons
blunt
efficaci
vector
presenc
preexist
immun
demonstr
gener
artifici
serotypespecif
immun
anim
preinocul
nonneutr
crossreact
antihadv
antibodi
gener
repeat
administr
infect
adv
serotyp
nonneutr
antibodi
also
significantli
reduc
transgen
express
fc
receptordepend
independ
mechan
result
poor
efficaci
adv
vector
cellular
compon
preexist
adv
immun
consist
cell
highli
crossreact
wide
preval
human
popul
epitop
recogn
antiadv
cell
locat
primarili
hexon
highli
conserv
among
variou
hadv
serotyp
impli
exposur
singl
hadv
serotyp
may
hamper
efficaci
hadv
serotyp
studi
reveal
cell
preval
human
subject
europ
unit
state
importantli
hadvspecif
cell
may
preval
even
absenc
nab
presenc
vectorspecif
cell
caus
cytolysi
elimin
vectortransduc
cell
cell
potenti
humor
immun
respons
vector
addit
develop
adapt
immun
respons
adv
vector
also
induc
immun
activ
character
overproduct
proinflammatori
cytokin
chemokin
high
level
type
interferon
ifn
complement
activ
phagocytosi
pattern
recognit
receptor
prr
involv
recognit
adv
vector
receptor
includ
tolllik
receptor
tlr
nucleotidebind
oligomer
domainlik
receptor
factor
x
retino
acidinduc
gene
bind
adv
prr
result
activ
downstream
signal
pathway
culmin
product
proinflammatori
mediat
includ
tumor
necrosi
factor
alpha
granulocyt
colonystimul
factor
macrophag
inflammatori
protein
mip
rant
monocyt
chemoattract
advinduc
innat
immun
respons
may
benefici
target
cancer
gene
therapi
vaccin
applic
goal
elimin
adv
vectortransduc
cell
gener
robust
immun
respons
howev
activ
innat
immun
respons
result
rapid
destruct
advtransduc
cell
thu
reduc
transgen
express
furthermor
intraven
inocul
larg
dose
adv
vector
also
lifethreaten
consequ
mediat
strong
activ
innat
immun
reaction
tremend
potenti
adv
vector
hamper
immun
respons
adv
success
vector
critic
understand
thoroughli
underli
mechan
sever
strategi
develop
circumv
preexist
immun
minim
innat
immun
reaction
adv
broadli
classifi
either
genet
chemic
modif
genet
modif
includ
hexon
pseudotyp
hexon
hvr
swap
fiber
pseudotyp
fiber
truncat
use
altern
trimer
motif
fiber
use
vector
deriv
rare
hadv
serotyp
nonhuman
adv
chemic
modif
includ
deriv
adv
vector
polyethylen
glycol
cation
polym
polyllysin
n
methacrylamid
argininegraft
bioreduc
polym
coat
adv
vector
cation
liposom
lipid
envelop
review
focu
adv
vector
deriv
nonhuman
adv
idea
develop
vector
deriv
nonhuman
adv
base
premis
nonhuman
adv
less
preval
consequ
lower
seropreval
among
human
popul
similar
hadv
nonhuman
adv
caus
seriou
diseas
natur
host
preexist
immun
nonhuman
adv
expect
natur
host
addit
overal
genom
organ
structur
featur
nonhuman
adv
vastli
differ
hadv
vector
design
strategi
techniqu
use
work
hadv
vector
could
principl
appli
nonhuman
adv
vector
initi
impetu
develop
nonhuman
adv
vector
seen
earli
limit
hadv
vector
start
becom
evid
sinc
gene
express
vector
base
variou
speci
nonhuman
adv
construct
extens
character
includ
simian
adv
serotyp
sadv
bovin
adv
serotyp
porcin
adv
serotyp
ovin
adv
serotyp
canin
adv
serotyp
murin
adv
serotyp
fowl
adv
serotyp
fadv
review
variou
aspect
nonhuman
adv
vector
includ
strategi
construct
type
vector
genom
organ
figur
insert
site
foreign
gene
insert
capac
receptor
tropism
impact
preexist
immun
preclin
clinic
studi
discuss
exampl
nonhuman
advbas
vector
gene
deliveri
vehicl
recombin
vaccin
gene
therapi
applic
shown
tabl
first
sadv
vector
develop
chimpanze
adv
chadv
base
vector
deriv
homolog
recombin
shuttl
vector
vector
genom
cell
line
express
earli
region
protein
appear
close
relat
thu
allow
effici
replic
similar
offer
two
advantag
need
creat
cell
line
express
chadv
less
chanc
vector
contamin
replicationcompet
adv
due
variat
common
sequenc
vector
addit
substanti
variat
hypervari
region
within
hexon
sequenc
sever
hadv
given
hypervari
region
hexon
carri
typespecif
epitop
hadvneutr
antibodi
surpris
crossneutr
hadv
preexist
immun
ab
loop
within
knob
domain
fiber
mediat
bind
carbind
hadv
serotyp
ident
similar
thu
explain
observ
car
serv
receptor
chadv
close
relat
subgroup
e
hadv
may
possibl
use
car
receptor
cell
entri
close
relat
subgroup
b
hadv
util
receptor
cell
entri
conceiv
tropism
chadv
vector
util
car
receptor
would
similar
car
bind
hadv
serotyp
depend
delet
without
earli
region
delet
vector
allow
transgen
length
bp
respect
without
signific
decreas
viru
yield
viru
particletopfu
ratio
compar
smaller
size
transgen
vector
compar
term
level
transgen
express
induct
transgenespecif
cell
respons
howev
incorpor
delet
result
decreas
transgen
express
cell
respons
interestingli
level
protein
express
vector
seem
function
transgen
length
vector
express
simian
immunodefici
viru
siv
gag
alon
result
much
higher
protein
express
vector
express
siv
gagpol
siv
gagpolnef
fusion
protein
consequ
result
higher
gagspecif
cell
respons
like
competit
peptid
mhc
class
peptidebind
site
decreas
overal
magnitud
immun
respons
gag
thu
even
though
vector
capabl
incorpor
larg
insert
choic
transgen
length
care
evalu
preexist
immun
chadv
show
great
potenti
gene
therapi
vaccin
vector
nonhuman
adv
vector
progress
clinic
trial
date
chadv
littl
seropreval
human
popul
worldwid
make
suitabl
vector
candid
use
human
hexon
chadv
hadv
littl
sequenc
similar
hypervari
region
locat
major
neutral
determin
suggest
chadv
circumv
preexist
immun
hadv
vector
low
frequenc
nab
chadv
rang
observ
human
unit
state
europ
thailand
china
wherea
nab
hadv
serotyp
may
reach
countri
sera
subsaharan
countri
found
posit
nab
chadv
wherea
sera
posit
nab
hadv
serotyp
brazil
seropreval
rate
chadv
nab
hadv
nab
depend
serotyp
therefor
even
though
seroreact
chadv
higher
subsaharan
countri
brazil
rest
world
still
lower
hadv
neutral
antibodi
titer
consid
hamper
efficaci
adv
vector
therefor
import
consid
titer
chadv
nab
anticip
less
human
sera
chadv
nab
titer
wherea
human
sera
posit
hadv
nab
titer
lower
titer
chadv
nab
combin
lower
overal
seroreact
compar
hadv
serotyp
suggest
chadv
serotyp
less
like
suffer
preexist
immun
hadv
serotyp
immunolog
potenti
chadv
vector
belong
group
c
hadv
speci
highest
immunogen
potenti
among
chadv
vector
subsaharan
africa
target
popul
endem
diseas
human
immunodefici
viru
hiv
malaria
tuberculosi
exist
particularli
import
vaccin
abil
induc
cell
respons
effect
hadv
serotyp
gener
cell
respons
would
ineffici
area
owe
modest
high
level
preexist
immun
hadv
serotyp
least
preexist
immun
worldwid
effect
gener
cell
respons
particular
overal
immunogen
gener
hiv
chadvderiv
vector
markedli
lower
seroreact
titer
across
popul
southern
africa
eastern
africa
central
africa
india
unit
state
south
america
caribbean
addit
chadv
vector
result
gagspecif
cell
respons
express
level
compar
better
hadv
serotyp
wide
rang
dose
chadv
vector
also
found
induc
siv
gagspecif
respons
better
addit
found
effect
boost
dna
prime
siv
gagspecif
cell
respons
heterolog
primeboost
regimen
chadv
vector
carri
gag
gene
result
strong
robust
cell
variou
system
compart
includ
genit
tract
intramuscular
immun
within
week
moreov
cell
respons
seem
long
last
gagspecif
cell
detect
system
compart
one
year
immun
observ
suggest
chadvbas
vector
use
develop
vaccin
infect
requir
cellmedi
immun
cmi
respons
singl
immun
chadv
vector
express
gag
elicit
potent
antigenspecif
cellular
immun
respons
spotform
cell
sfc
per
million
pbmc
contract
eventu
persist
beyond
year
sfc
per
million
pbmc
booster
year
stage
chadv
vector
carri
antigen
result
rapid
increas
number
gagspecif
produc
cell
addit
gagspecif
antibodi
could
detect
booster
increas
factor
booster
impli
chadv
vector
capabl
induc
longlast
b
cell
memori
recent
report
compar
immunolog
potenc
anticanc
vaccin
vector
vector
express
transgen
level
similar
abl
induc
higher
level
cell
respons
significantli
lower
dose
compar
vector
addit
stronger
immun
respons
observ
primeboost
regimen
either
primeboost
regimen
importantli
vector
abl
confer
antitumor
protect
mice
immun
anoth
studi
report
also
known
deriv
vector
equal
effici
vector
transduc
lowpassag
brain
tumor
cell
glioma
tumor
stem
cell
deriv
human
patient
given
cell
difficult
treat
tradit
chemotherapi
aforement
observ
warrant
test
vector
treatment
human
brain
tumor
chadvbas
vector
capabl
induc
robust
humor
cellular
adapt
immun
respons
also
shown
induc
protect
immun
varieti
infect
includ
ebola
viru
mice
nonhuman
primat
respiratori
syncyti
viru
neonat
sever
acut
respiratori
syndrom
viru
abil
induc
protect
immun
human
popul
presenc
preexist
immun
hadv
serotyp
highli
desir
trait
chadvbas
vector
vector
potenti
develop
common
platform
vaccin
gene
therapi
purpos
heterolog
primeboost
regimen
vector
combin
plasmid
dna
modifi
vaccinia
vector
ankara
mva
vaccin
deliv
hivconsv
evalu
uninfect
human
subject
hivconsv
base
function
conserv
subprotein
domain
common
viru
variant
worldwid
combinatori
regimen
includ
result
hivconsvspecif
cell
remark
high
frequenc
furthermor
cell
broad
specif
multipl
intercellular
signal
molecul
induc
addit
effector
cell
found
specif
gag
pol
efficaci
inhibit
replic
cultur
autolog
cell
factor
log
advers
side
effect
report
subject
receiv
vaccin
formul
followup
phase
clinic
trial
hivcor
combinatori
regimen
discuss
report
signific
safeti
toler
concern
mildtomoder
local
reactogen
system
effect
mild
pain
erythema
fever
headach
last
fewer
day
postadministr
describ
major
vaccin
receiv
follow
encourag
result
phase
clinic
trial
use
mvahivconsv
underway
clinicaltrialsgov
malaria
malaria
caus
plasmodium
falciparum
major
pathogen
respons
childhood
morbid
mortal
africa
countri
primari
object
effect
malaria
vaccin
control
diseas
transmiss
multipl
preclin
studi
demonstr
strong
correl
cell
protect
efficaci
howev
exist
subunit
vaccin
good
enough
induc
high
level
malaria
antigenspecif
cell
sever
studi
shown
heterolog
primeboost
immun
mva
express
metrap
liver
stage
antigen
p
falciparum
capabl
induc
robust
cell
respons
protect
metrap
mvametrap
caus
signific
local
system
advers
effect
demonstr
good
safeti
profil
individu
kenya
gambia
unit
kingdom
dose
metrap
mvametrap
primeboost
regimen
induc
high
frequenc
antigenspecif
secret
cell
reach
beyond
sfcsmillion
pbmc
two
independ
phase
ib
clinic
trial
induc
cellular
immun
respons
includ
cytokin
secret
antigenspecif
cell
popul
addit
respons
seem
long
last
sinc
significantli
decreas
month
postvaccin
high
level
antigenspecif
secret
cell
highli
remark
difficult
induc
sfcsmillion
pbmc
prime
follow
mvametrap
boost
induc
high
level
igg
respons
trap
antigen
importantli
low
level
nab
titer
detect
preand
postadministr
attenu
immunogen
vaccin
final
mvametrap
primeboost
also
provid
steril
partial
protect
control
human
malaria
infect
heterolog
malaria
strain
therebi
demonstr
strong
correl
immunogen
protect
efficaci
anoth
heterolog
primeboost
vaccin
regimen
employ
mva
encod
either
one
blood
stage
malaria
antigen
amai
mspi
alon
combin
liver
stage
antigen
metrap
vector
display
excel
safeti
profil
induc
significantli
higher
cell
respons
compar
deliveri
platform
test
dnamva
fowl
pox
virusmva
cellular
immun
respons
broadli
specif
persist
high
level
compris
relev
cytokin
secret
cell
popul
vector
also
induc
antigenspecif
igg
respons
primeboost
combin
commonli
employ
versatil
vaccin
deliveri
system
capabl
induc
strong
cellular
humor
immun
respons
hepat
c
hepat
c
viru
hcv
anoth
pathogen
immens
public
health
signific
chadvderiv
vector
use
vaccin
deliveri
hcv
capabl
establish
persist
stealthi
infect
immunocompet
host
cirrhosi
affect
signific
portion
liver
current
treatment
becom
increasingli
effect
costli
seriou
side
effect
induct
high
level
virusspecif
cell
import
protect
hcv
impli
success
hcv
vaccin
abl
mount
strong
longlast
cell
respons
vector
alongsid
rare
hadv
serotyp
express
ns
protein
hcv
genotyp
recent
test
phase
clinic
trial
vector
found
overal
safe
well
toler
result
mild
local
system
side
effect
variou
dose
rang
vp
vector
use
vp
dose
induc
sfcsmillion
pbmcsa
level
similar
higher
vector
furthermor
viral
vector
abl
induc
broad
cell
respons
target
peptid
encompass
multipl
viral
gene
product
includ
induc
cell
respons
vector
includ
cell
respons
domin
two
cell
popul
secret
three
cytokin
detect
minim
respons
addit
induc
cell
respons
found
crossreact
hcv
genotyp
genotyp
repres
immunogen
final
detect
function
memori
cell
could
observ
one
year
postboost
suggest
vaccin
induc
longlast
cell
respons
clinic
trial
also
test
heterolog
primeboost
regimen
boost
regimen
contrast
boost
regimen
result
stronger
boost
respons
also
consist
among
differ
vaccin
howev
boost
respons
still
high
observ
boost
malaria
trial
poorer
boost
respons
surpris
given
strong
function
respons
prime
author
propos
nab
induc
prime
possibl
interf
heterolog
vector
use
prime
result
attenu
adv
vectorspecif
ns
antigenspecif
cell
respons
nonetheless
overal
find
clinic
trial
cellbas
hcv
vaccin
demonstr
util
chadv
vector
vaccin
deliveri
platform
adv
infect
cattl
term
bovin
adv
badv
classifi
two
genera
mastadenoviru
atadenoviru
ten
serotyp
badv
isol
thu
far
respons
mild
diseas
gastrointestin
respiratori
tract
bovin
badv
serotyp
best
character
complet
nucleotid
sequenc
genom
map
avail
genom
share
high
level
similar
certain
differ
region
rel
smaller
less
complex
compar
correspond
region
protein
show
function
amino
acid
sequenc
homolog
counterpart
protein
complement
function
suggest
function
similar
structur
fiber
except
long
bent
sever
site
indic
bend
may
necessari
allow
penton
base
make
contact
secondari
receptor
cell
surfac
cotton
rat
sigmodon
hispidu
serv
replicationcompet
smallanim
model
evalu
pathogenesi
vaccin
efficaci
vector
presenc
circul
antibodi
intranas
inocul
cattl
result
inappar
infect
suggest
vaccin
would
success
vector
creat
use
homolog
recombin
mammalian
cell
bacteria
addit
isceibas
approach
sever
bovin
cell
line
use
rescu
badvbas
vector
includ
mdbk
bovin
human
hybrid
cell
line
express
fetal
bovin
retin
cell
express
vido
fetal
bovin
retin
cell
express
initi
replicationcompet
vector
contain
firefli
luciferas
gene
region
construct
number
find
explor
potenti
gene
deliveri
platform
antibodi
rais
rabbit
mice
crossviru
neutral
report
gene
express
mice
significantli
higher
p
obtain
anim
intern
independ
receptor
car
util
link
well
link
sialic
acid
major
receptor
intern
preexist
hadvneutr
antibodi
human
crossneutr
hadvspecif
cmi
respons
cross
react
tropism
distinct
effici
transduc
divers
human
nonhuman
cell
cultur
unlik
strong
induc
absenc
kupffer
cell
deplet
mice
kupffer
cell
deplet
main
reason
faster
vector
deplet
host
intraven
inocul
vector
effici
transduc
heart
kidney
lung
liver
spleen
vector
persist
longer
durat
compar
vector
especi
heart
kidney
lung
mous
model
sequenti
administr
vector
overcom
vector
immun
immunocompet
mous
model
breast
cancer
persist
genom
human
nonhuman
cell
line
similar
vector
variou
find
underscor
vector
offer
attract
altern
hadv
vector
effect
immun
individu
high
level
preexist
hadv
immun
safeti
aspect
similar
vector
vector
success
use
gene
deliveri
vaccin
purpos
experiment
anim
intranas
vaccin
cotton
rat
replicationcompet
vector
express
bovin
gdt
glycoprotein
induc
strong
gdspecif
iga
igg
immun
respons
subsequ
studi
vaccin
calv
induc
gdspecif
antibodi
respons
serum
nasal
secret
confer
protect
challeng
vector
express
bovin
viral
diarrhea
viru
glycoprotein
induc
iga
igg
nasal
secret
serum
respect
cotton
rat
follow
intranas
immun
vector
coexpress
bovin
respiratori
syncyti
viru
glycoprotein
g
bovin
region
develop
vector
coexpress
bovin
respiratori
syncyti
viru
g
protein
gener
vaccin
cotton
rat
induc
strong
antigenspecif
immun
respons
order
evalu
whether
badv
vector
effect
elud
high
level
preexist
vector
immun
mice
immun
badv
vector
express
ha
influenza
viru
even
presenc
high
level
neutral
antibodi
titer
reduct
haspecif
humor
cmi
respons
observ
mice
immun
presenc
except
high
level
preexist
vector
immun
mice
immun
result
approxim
higher
hemagglutin
inhibit
hi
titer
higher
percentag
haspecif
cell
compar
level
mice
inocul
immun
hadvprim
mice
result
full
protect
morbid
mortal
follow
potenti
lethal
challeng
ahong
furthermor
heterolog
primeboost
regimen
compris
prime
boost
elicit
significantli
higher
hi
respons
compar
alon
result
strongli
suggest
import
use
badvbas
vector
altern
hadvbas
vector
elud
preexist
vector
immun
heterolog
primeboost
strategi
enhanc
immun
respons
adv
isol
pig
term
porcin
adv
padv
five
serotyp
padv
current
known
infect
swine
similar
adv
padv
preval
primarili
swine
speci
respons
gastrointestin
diseas
multifactori
porcin
respiratori
diseas
complex
among
five
padv
preval
wellcharacter
serotyp
initi
isol
healthi
young
piglet
associ
subclin
infect
complet
nucleotid
sequenc
transcript
map
avail
share
genom
structur
similar
like
belong
genu
mastadenoviru
genom
consist
five
earli
transcript
unit
transact
unit
shown
complement
function
transcript
unit
howev
unlik
intern
cell
independ
car
v
v
integrin
receptor
primari
receptor
distinct
antibodi
rais
rabbit
mice
crossneutr
report
gene
express
mice
show
significantli
higher
p
valu
p
obtain
anim
preexist
hadvspecif
neutral
antibodi
human
crossneutr
vector
effici
transduc
number
human
murin
porcin
bovin
cell
cultur
suggest
vector
promis
supplement
hadv
vector
studi
biodistribut
vector
compar
vector
mous
model
show
rapid
vector
clearanc
linear
episom
form
vector
genom
detect
inocul
mice
addit
cell
respons
show
signific
crossreact
compar
vector
vector
induc
higher
level
innat
immun
respons
includ
tlr
proinflammatori
chemokin
cytokin
persist
vector
number
cell
line
compar
vector
linear
episom
form
vector
genom
observ
find
suggest
uniqu
receptor
usag
highlight
potenti
elud
hadvspecif
humor
cmi
respons
safeti
similar
vector
construct
recombin
vector
pursu
use
homolog
recombin
escherichia
coli
gener
fulllength
infecti
clone
follow
transfect
fetal
porcin
retin
cell
line
transform
vido
replicationcompet
contain
delet
region
replicationdefect
contain
delet
andor
region
padv
vector
develop
evalu
deliveri
tool
vaccin
gene
therapi
purpos
classic
swine
fever
viru
csfv
vaccin
contain
gene
csfv
weybridg
strain
righthand
end
genom
develop
transgen
express
driven
major
late
promot
tripartit
leader
sequenc
subcutan
vaccin
outbr
pig
singl
dose
vaccin
induc
high
level
antibodi
confer
complet
protect
lethal
challeng
csfv
furthermor
vaccin
anim
show
advers
clinic
sign
csfv
subsequ
studi
wean
pig
prewean
piglet
vaccin
dna
vaccin
express
gene
csfv
boost
primeboost
vaccin
approach
induc
high
level
antibodi
titer
follow
challeng
cfsv
wean
pig
prewean
piglet
protect
similarli
pseudorabi
viru
prv
vaccin
encod
glycoprotein
gene
prv
strain
develop
vaccin
pig
singl
two
dose
vaccin
induc
high
level
serumneutr
antibodi
prv
confer
protect
challeng
prv
viru
pig
vaccin
two
dose
vaccin
rel
higher
prv
antibodi
titer
demonstr
better
protect
efficaci
compar
receiv
singl
vaccin
dose
influenza
vaccin
express
ha
ahanoi
viru
evalu
potenti
induc
protect
immun
mice
vaccin
balbc
mice
induc
high
level
haspecif
humor
cellular
respons
vaccin
mice
protect
lethal
challeng
highli
pathogen
avian
influenza
viru
interestingli
compar
vaccin
immun
induc
present
even
twelv
month
postvaccin
addit
also
investig
gene
deliveri
tool
tuboli
cowork
develop
recombin
vector
encod
spike
gene
transmiss
gastroenter
viru
oral
vaccin
pig
induc
high
level
spikespecif
antibodi
like
adv
vector
preval
padvneutr
antibodi
swine
popul
thought
hinder
use
padv
vector
vaccin
purpos
survey
immun
pig
australia
demonstr
preval
virusneutr
antibodi
howev
studi
evalu
perform
presenc
high
level
antibodi
demonstr
effect
inhibit
presenc
elev
level
antibodi
sinc
preexist
hadvspecif
neutral
antibodi
human
crossneutr
vector
would
promis
supplement
hadv
vector
deliveri
vehicl
recombin
vaccin
gene
therapi
applic
human
adv
isol
sheep
term
ovin
adv
oadv
sinc
seven
serotyp
oadv
isol
classifi
belong
genu
mastadenoviru
belong
genu
atadenoviru
virus
associ
either
respiratori
tract
intestin
tract
infect
among
serotyp
well
character
evalu
gene
deliveri
vector
nucleotid
sequenc
seven
oadv
serotyp
current
avail
genom
organ
distinct
adv
genu
mastadenoviru
sinc
genom
rich
moreov
lack
clear
distinguish
region
entri
cell
independ
car
vivo
tissu
tropism
distinct
vector
creat
use
homolog
recombin
e
coli
cosmidbas
approach
follow
viru
rescu
ovin
fetal
lung
cell
line
ovin
fetal
skin
fibroblast
cell
line
transgen
express
three
uniqu
site
refer
site
ii
iii
genom
site
locat
pviii
fiber
gene
site
ii
present
within
gene
approxim
bp
end
viral
genom
site
iii
locat
within
short
noncod
region
present
rightend
transcript
region
site
iii
consid
stabl
among
three
insert
site
result
high
level
transgen
express
independ
orient
moreov
vector
site
iii
insert
easi
rescu
grow
high
titer
hcv
vaccin
encod
nonstructur
protein
hcv
bk
strain
develop
transgen
insert
site
iii
driven
rsv
ltr
intramuscular
immun
balbc
mice
induc
high
level
tlymphocyt
measur
elispot
assay
interestingli
cell
respons
persist
week
postvaccin
moreov
cell
respons
alter
presenc
immun
anoth
studi
oadvbas
vector
encod
protect
recombin
antigen
taenia
ovi
gener
evalu
immunogen
protect
efficaci
sheep
use
alon
combin
dnabas
ovi
vaccin
immun
sheep
two
dose
either
oadv
dna
vaccin
induc
low
level
antibodi
respons
howev
immun
dna
vaccin
follow
boost
oadvbas
vaccin
induc
antibodi
respons
higher
vaccin
either
dna
oadv
vaccin
alon
confer
protect
challeng
ovi
vaccin
oadvhiva
encod
clade
consensu
gagderiv
protein
coupl
cell
polyepitop
develop
vaccin
mice
oadvhiva
either
alon
combin
mvavector
vaccin
induc
high
level
cell
respons
necessari
confer
protect
studi
demonstr
potenti
deliveri
vehicl
hiv
vaccin
furthermor
feasibl
use
oadvhiva
combin
bcghiva
mycobacterium
bovi
bacillu
bcg
base
mvahiva
evalu
unfortun
vaccin
bcghiva
alon
induc
undetect
weak
tcell
respons
balbc
mice
rhesu
macaqu
respect
howev
prime
bcghiva
follow
boost
mvahiva
oadv
hiva
induc
robust
tcell
respons
recombin
vector
express
human
antitrypsin
gene
oavhaat
gener
evalu
util
human
gene
therapi
skelet
muscl
inject
low
dose
infecti
particl
oavhaat
result
high
serum
level
haat
ngml
accompani
weak
immun
respons
vector
infect
restrict
smooth
muscl
level
haat
express
compar
vector
express
haat
gene
system
administr
singl
dose
vector
encod
e
coli
purin
fludarabin
phosphorylas
gene
follow
prodrug
fludarabin
phosphat
significantli
inhibit
progress
prostat
cancer
immunocompet
adenovir
vector
gene
therapi
mous
model
role
vector
express
ovalbumin
ova
evalu
induc
antitumor
immun
mous
model
incub
bone
marrowderiv
dendrit
cell
vector
express
ova
result
upregul
costimulatori
marker
product
splenocyt
collect
immun
anim
activ
respond
vitro
antigen
stimul
furthermor
vivo
cytotox
assay
demonstr
effici
kill
antigen
peptidepuls
target
cell
mice
inocul
tumor
cell
immun
significantli
suppress
tumor
growth
studi
highlight
potenti
oadv
potenti
vehicl
gene
deliveri
vaccin
gene
therapi
purpos
neutral
antibodi
oadv
preval
human
make
oadv
vector
promis
tool
gene
deliveri
human
canin
adv
cadv
serotyp
well
character
dog
respons
infecti
canin
hepat
wherea
caus
mild
upper
respiratori
tract
infect
despit
long
histori
cohabit
dog
human
cadv
abl
cross
specif
barrier
associ
human
diseas
complet
genom
sequenc
vector
system
base
develop
homolog
recombin
bacteria
vector
develop
late
insert
capac
kb
strategi
employ
construct
vector
involv
homolog
recombin
viral
genom
shuttl
vector
carri
transgen
express
cassett
along
necessari
sequenc
similar
use
gener
hadv
vector
vector
transcompl
cell
line
express
human
necessit
develop
canin
kidney
cell
line
express
vector
grown
high
titer
vpml
seem
excel
infecti
particlestoviru
particl
ratio
howev
initi
system
vector
develop
cumbersom
ineffici
often
result
vector
titer
fold
lower
vector
appar
canin
kidney
cell
difficult
transfect
linear
vector
genom
kb
recent
improv
system
vector
gener
describ
use
canin
kidney
cell
line
transcompl
express
iscei
fuse
estrogen
receptor
system
allow
highli
effici
transfect
supercoil
vector
genom
canin
kidney
cell
follow
intracellular
releas
vector
genom
result
increas
vector
titer
condit
replic
adv
crad
vector
base
develop
show
effici
replic
oncolyt
potenti
canin
cell
line
mous
xenograft
model
subsequ
studi
demonstr
enhanc
bind
intern
crad
vector
canin
osteosarcoma
cell
vector
modif
incorpor
polylysin
cterminu
fiber
knob
tropism
distinct
overlap
cell
transduc
also
transduc
vice
versa
util
car
receptor
depend
integrin
heavi
chain
mhci
entri
interestingli
capsid
lack
rgd
motif
penton
base
requir
interact
integrin
also
interact
adv
receptor
lactoferrin
replicationdefect
human
cell
although
infect
human
cellsa
highli
desir
trait
prevent
complic
caus
replicationcompet
adv
contamin
vector
preferenti
transduc
rodent
olfactori
neuron
central
nervou
system
cn
neuron
vitro
vivo
demonstr
effici
retrograd
axon
transport
follow
intramuscular
intrastriatum
inject
allow
transgen
express
throughout
substantia
nigra
inject
vector
multipl
site
striatum
instead
singl
site
result
five
time
dopaminerg
neuron
substantia
nigra
suggest
multipl
site
inject
strategi
could
prove
effect
larg
area
cn
target
vector
capabl
transduc
young
mous
neuron
without
affect
function
matur
neuron
addit
vector
induc
signific
cellular
infiltr
rat
brain
reflect
poor
immunogen
cn
collect
observ
suggest
vector
could
prove
effect
tool
therapi
neurodegen
diseas
requir
widespread
express
transgen
cn
without
complic
aris
cellular
infiltr
result
unintend
immun
activ
addit
cn
vector
effici
transduc
mous
airway
epitheli
cell
vitro
ex
vivo
vivo
human
sera
contain
high
level
antibodi
demonstr
littl
detect
neutral
addit
sera
mice
contain
except
high
level
titer
antibodi
affect
transduct
caus
greater
inhibit
vitro
similarli
preexist
hadv
immun
significantli
affect
transduct
murin
respiratori
tract
collect
observ
impli
preexist
hadv
immun
affect
transduct
vector
effect
tool
circumv
preexist
adv
immun
addit
cradv
vector
helperdepend
hd
vector
also
develop
base
strategi
construct
hd
vector
involv
homolog
recombin
e
coli
plasmid
contain
itr
without
packag
sequenc
kb
stuffer
sequenc
shuttl
plasmid
pgut
contain
transgen
express
cassett
itr
packag
sequenc
kb
overlap
region
hd
adv
vector
gener
transfect
complement
cell
line
linear
hd
vector
genom
follow
infect
helper
viru
amplif
hd
vector
also
requir
coinfect
helper
viru
sever
round
amplif
hd
vector
purifi
cesium
chlorid
densiti
gradient
flank
packag
domain
helper
viru
loxp
site
prevent
signific
level
contamin
vector
helper
viru
cremedi
excis
loxp
site
effici
howev
mutat
cisact
sequenc
packag
domain
helper
viru
reduc
contamin
hd
vector
prepar
final
titer
infecti
unitsml
particl
ml
addit
replicationcompet
adv
could
detect
particl
multipl
round
amplif
importantli
hd
vector
capabl
induc
longterm
sustain
transgen
express
rat
brain
last
least
one
year
postinject
hd
vector
also
induc
transgen
express
last
month
postinstil
mous
upper
respiratori
tract
month
decreas
detect
compar
earlier
time
point
like
due
natur
turnov
pulmonari
epithelium
addit
hd
vector
induc
degre
innat
immun
respons
mous
lung
level
induct
lower
induc
vector
hd
vector
also
test
use
therapi
mucopolysaccharidosi
mp
type
vii
result
defici
manifest
corneal
cloud
due
accumul
glycosaminoglycan
gag
hd
vector
encod
human
hdrigi
effici
transduc
carposit
keratocyt
mice
nonhuman
primat
follow
direct
intrastrom
inject
apart
temporari
corneal
edema
last
h
major
complic
occur
vector
transduct
effici
vector
cover
entir
cornea
declin
week
suggest
improv
necessari
obtain
longterm
express
interestingli
vector
induc
histolog
correct
gag
cell
morpholog
canin
cornea
possibl
due
car
express
keratocyt
highlevel
express
vector
addit
hdrigi
could
also
revers
neuropatholog
chang
associ
mp
vii
dog
brain
hdrigi
potenti
induc
longterm
express
mice
result
decreas
gag
level
lysosom
enzym
activ
importantli
dramat
improv
cognit
function
reason
hd
vector
potenti
provid
tool
therapi
mp
vii
lysosom
storag
diseas
murin
adv
classifi
genu
mastadenovirusspeci
b
c
murin
adv
serotyp
first
isol
character
use
model
system
explor
virushost
interact
adv
pathogenesi
antivir
therapi
infect
caus
seriou
diseas
newborn
adult
mice
infect
even
low
dose
newborn
mice
caus
seriou
mortal
howev
akin
hadv
infect
immunocompet
adult
mice
caus
mild
infect
low
mortal
unlik
hadv
initi
infect
respiratori
epithelium
replic
primari
endotheli
cell
variou
bodi
system
thu
result
widespread
system
infect
affect
liver
spleen
kidney
intestin
adren
heart
brain
spinal
cord
genom
kbp
similar
organ
except
encod
virusassoci
rna
vector
base
first
describ
late
vector
construct
either
replac
initi
codon
stop
codon
delet
three
conserv
region
within
vector
grew
titer
one
log
lower
wildtyp
viru
mous
fibroblast
impli
essenti
effici
viru
replic
delet
alter
gene
express
level
earli
region
gene
suggest
unlik
hadv
requir
transactiv
earli
region
gene
howev
pathogen
null
mutant
significantli
lower
wildtyp
viru
suggest
requir
host
cell
cultur
region
encod
three
protein
common
ntermin
sequenc
uniqu
ctermin
sequenc
vector
construct
mutagenesi
block
express
one
protein
mutant
induc
significantli
less
endotheli
cell
damag
inflammatori
respons
brain
spinal
cord
wildtyp
viru
indic
role
protein
area
util
car
primari
receptor
contain
rgd
motif
penton
base
instead
fiber
knob
domain
carri
rgd
motif
play
import
role
entri
mediat
addit
cell
surfac
glycosaminoglycan
heparan
sulfat
also
involv
infect
bind
primari
human
smooth
muscl
significantli
higher
affin
biodistribut
alter
presenc
physiolog
concentr
coagul
factor
xi
vitamin
kdepend
factor
play
role
target
liver
although
bind
factor
xi
contrari
bind
result
cell
attach
consequ
target
liver
significantli
lower
vector
carri
delet
region
shown
excel
oncolyt
adv
system
help
understand
mechan
action
oncolyt
adv
immunocompet
host
abil
replic
immunocompet
host
particularli
noteworthi
oncolyt
adv
vector
base
replic
mous
tissu
therefor
safeti
efficaci
adequ
evalu
viru
replic
effici
murin
tumor
cell
replic
attenu
nontransform
cell
addit
demonstr
potent
antitumor
activ
immunocompet
xenograft
tumor
model
feasibl
approach
arm
viru
immunomodulatori
molecul
enhanc
antitumor
efficaci
also
use
model
understand
pathogen
mechan
pediatr
myocard
acut
respiratori
infect
caus
adv
sever
adv
isol
bird
includ
fowl
fadv
falcon
faadv
goos
goadv
duck
dadv
turkey
tadv
virus
includ
genu
aviadenoviru
group
four
serotyp
faadv
ae
goadv
dadv
tadv
b
duck
adv
adv
egg
drop
syndrom
viru
also
known
duck
adv
includ
genu
atadenoviru
base
uniqu
genom
structur
characterist
virus
serolog
distinct
adv
genera
infect
bird
complet
nucleotid
sequenc
five
aviadenoviru
speci
determin
genom
aviadenovirus
larger
adv
rang
size
bp
furthermor
genom
organ
aviadenovirus
distinct
compar
adv
contain
high
g
c
content
rang
virion
contain
two
fiber
per
penton
base
genom
aviadenovirus
lack
gene
encod
v
ix
protein
aviadenoviru
genom
contain
sever
uncharacter
transcript
unit
right
end
uniqu
genu
fadvbas
vector
devoid
creat
use
homolog
recombin
e
coli
cosmidbas
approach
follow
transfect
permiss
leghorn
male
hepatoma
cell
three
aviadenovirus
evalu
gene
deliveri
vector
vaccin
vector
contain
gene
australian
classic
strain
infecti
bursal
diseas
viru
ibdv
gener
vaccin
specif
pathogenfre
chicken
vaccin
induc
antibodi
protect
chicken
challeng
ibdv
strain
vector
evalu
cancer
gene
therapi
demonstr
effici
transduct
sever
human
cell
includ
primari
human
dermal
fibroblast
anoth
studi
vaccin
develop
infecti
bronchiti
viru
ibv
incorpor
spike
peplom
subunit
ibv
vic
strain
control
fadv
major
late
promot
use
vectorbas
vaccin
immun
commerci
broiler
chicken
induc
antibodi
respons
confer
protect
challeng
either
vic
serotyp
b
serotyp
c
strain
ibv
vector
express
cytokin
includ
chicken
develop
evalu
enhanc
immunogen
vaccin
chicken
number
nonhuman
adv
includ
simian
sadv
bovin
badv
porcin
padv
canin
cadv
ovin
oadv
murin
madv
fowl
fadv
variou
stage
develop
gene
deliveri
system
recombin
vaccin
gene
therapi
applic
addit
effect
circumv
preexist
hadv
immun
nonhuman
adv
vector
util
number
receptor
addit
car
vector
intern
therebi
expand
rang
cell
type
target
safeti
aspect
vector
appear
similar
better
hadv
vector
addit
util
human
applic
nonhuman
adv
vector
also
provid
excel
platform
veterinari
vaccin
specif
nonhuman
adv
vector
use
speci
origin
could
provid
excel
anim
model
evalu
efficaci
pathogenesi
vector
mechan
activ
innat
immun
includ
tlr
express
nonhuman
adv
need
determin
fulli
explor
potenti
gene
deliveri
system
vector
use
primeboost
approach
adv
vector
gene
deliveri
system
includ
dna
immun
viral
bacteri
vector
situat
multipl
vector
inocul
requir
desir
effect
nonhuman
adv
vector
could
supplement
hadv
viral
vector
sadv
vector
grown
certifi
human
cell
line
use
hadv
replic
purif
therefor
need
certifi
number
cell
line
suitabl
grow
purifi
nonhuman
adv
vector
fulli
exploit
desir
impact
use
nonhuman
adv
chang
nonhuman
adv
vector
design
necessari
